David Pardoe

David Pardoe is a versatile professional with a strong background in creating new business models and systems to advance technology and scientific research outcomes for patient benefit.

With a wealth of experience in VP Scientific Strategy and management roles at various renowned organizations including GSK, LifeArc, PA Consulting Group, and adMare BioInnovations, David has demonstrated his expertise in applying early-stage technologies to solve real-world problems.

David's career as a medicinal chemist specializing in research for new therapies spans across diverse therapeutic areas such as neuroscience, cardiology, pain, and immune disease, showcasing his broad knowledge in pharmaceutical sciences, drug discovery, preclinical development, and scientific leadership.

An alumnus of the University of Bristol with a PhD in Medicinal Chemistry and Nottingham Trent University with a BSc (Hons) in Applied Chemistry, David has a solid educational foundation to support his professional journey.

Currently serving as the SVP Global Head of Molecular Architects at Evotec, David has held key positions in top organizations like LifeArc, GSK, and PA Consulting Group, contributing significantly to advancements in the life sciences industry.